Forum Markets Inc. – Corporate Update and Market Performance
Market Overview
- On Friday, 23 November 2026, Forum Markets (FRMM) closed 24 hours trading at a decline of 6.2 %.
- The share price at 11:53 PM Central Europe was approximately USD 3.38 on major exchanges.
- The company’s market capitalization stands at USD 46.9 million.
- In the preceding 24 hours, roughly USD 901,100 of Forum Markets shares were traded.
- The 200‑day simple moving average is USD 4.55.
- The all‑time high for the past 52 weeks was USD 24.44, reached on 28 October 2025.
- The 52‑week low was USD 1.76, recorded on 13 April 2026.
Upcoming Investor Disclosure
- Forum Markets Inc. will release its third‑quarter 2026 financial results before the U.S. market opens on Thursday, 12 November 2026.
- The company’s chairman, CEO, and CFO will host a live webcast on that day to discuss the results and operational developments.
- A recording of the session will remain available for one year on the firm’s investor website.
Business Focus
- Forum Markets specializes in sourcing and operating cash‑generating assets across AI infrastructure, commercial aerospace, manufactured housing finance, and auto credit.
- The company combines proprietary origination pipelines with strategic co‑investment partnerships to expand its portfolio and generate durable operating income.
- Its approach merges traditional asset‑management principles with active operational execution to create a new framework for owning, managing, and monetizing real‑world assets.
Peer Performance (24‑hour snapshot)
| Ticker | Trade % Change | Current Price | Market Cap (USD m) | Additional Notes |
|---|---|---|---|---|
| PGAC | +0.37 % | USD 10.87 | 55.5 | P&C has a P/E ratio of 57.3 |
| TRT | –4.09 % | USD 5.04 | 55.9 | Short‑sale disclosed: 1.5 % of shares (Walleye Capital LLC) |
| DLHC | –3.38 % | USD 3.77 | 55.8 | – |
| RNXT | +2.50 % | USD 1.29 | 55.5 | – |
| TLPH | –1.87 % | USD 1.08 | 55.5 | – |
Additional Corporate Information
- Forum Markets is not to be confused with 180 Life Sciences Corp., a biotech firm listed on Nasdaq with an IPO on 2 June 2017.
This article presents factual information derived from market data and corporate announcements as of 23 November 2026.
